NSE filing, NSE: MAXHEALTH. Summary written from the filing by ALFA Finder's alert engine.
Max Healthcare Institute Ltd: key numbers
- Share price
- ₹851.50
- Market cap
- ₹82,877 Cr
- Revenue (annual)
- ₹8,373 Cr
- Net profit (annual)
- ₹1,442 Cr
- P/E (TTM)
- 56.9×Sector 51.1×
- Promoter holding
- 23.71%+0.00% QoQ
- FII holding
- 40.52%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Max Healthcare Institute Ltd
All →Max Healthcare Institute Annual General Meeting
Max Healthcare shareholders approved special resolutions by postal ballot on 19-Oct-2026. These cover a PRSU scheme for up to 73.5 lakh shares, remuneration for the Chairman and MD, and an alteration of the MoA objects clause.
Max Healthcare Institute Board Meeting Date
Max Healthcare's board meets on 30-Oct-2026 to consider unaudited quarterly and half-year results. The trading window stays closed until 48 hours after results.
Max Healthcare Institute Employee Stock Options
Max Healthcare Institute Limited has instituted the MHIL PRSU Scheme 2026. The scheme covers up to 73.50 lakh equity shares for employee stock-based incentives.
Max Healthcare Institute Annual General Meeting
Max Healthcare Institute announced the postal ballot voting results. Shareholders approved the Performance Linked Restricted Stock Unit Scheme 2026 and other special resolutions.
Max Healthcare Institute Other Announcement
Max Healthcare Institute Limited received an independent ESG rating of '66' from NSE Sustainability Ratings and Analytics. The rating for FY 2025-26 was assigned based on public disclosures.
Max Healthcare Institute Credit Rating
Max Healthcare's CARE AA+ (Stable) long-term and A1+ short-term credit ratings on bank facilities are reaffirmed. No change in rating outlook or amounts.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.